Compugen CGEN Stock Today Rallies 070 Resistance at 301 20260514 Align Health ALHC Stock Today Rallies 350 Resistance at 1709 20260518 Manitowoc MTW Slips 438 Testing 1078 Support 20260519 JStar YMAT Stock Analysis Falls 1171 Watching 157 20260515 ABM Industries Stock Gains Momentum as Shares Approach Key Resistance ATT CEO Highlights BlueCollar Worker Shortage in AIDriven Economy Nvidia Acknowledges Largely Conceding Chinas AI Chip Market to Huawei Prediction Market Signals Rising Odds of Federal Reserve Rate Hike by July 2027 Gentell CEO Navigates Oil Price Shock Amid Strait of Hormuz Crisis US National Debt Reaches 100 of GDP for First Time Since WWII Era Booz Allen Hamilton Q4 Earnings Highlights Government Contractor Reports Results Amid Evolving Defense Landscape Oil Prices Slide Amid Hopes of Iran Strait of Hormuz Deal Rubio Warns of Alternative Measures Best Cars for Rideshare Drivers in 2026 Kia Soul and Honda Odyssey Lead Recommendations Retail Chain Closing All Stores After 33 Years Latest Signal of Struggling BrickandMortar Sector RZB Q1 2026 Earnings Strong Earnings Beat Bolsters Credit Profile SKIL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher PAPL Q3 2025 Earnings EPS Surprises Positively Despite Revenue Uncertainty Stock Declines Byline Bancorp Inc Q1 2026 Earnings EPS Surpasses Estimates by 755 Shares Edge Higher Instil Bio Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment How to Save Money on Gas and Diesel Ahead of Memorial Day Weekend Travel PTHS Q1 2026 Earnings Narrowed Loss Per Share Beats Estimates No Revenue Yet Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage Chicago Atlantic Real Estate Finance Inc REFI Q1 2026 Earnings Earnings Miss Estimates Amid Higher Expenses RPT Q1 2026 Earnings Significant EPS Miss Stock Declines FirstCash Holdings FCFS Q1 2026 Earnings Strong EPS Beat Driven by Operational Discipline Saratoga Investment Corp 600 Notes due 2027 SAT Q1 2026 Earnings Significant Miss as EPS Falls to 016 LCTX Q1 2026 Earnings EPS Misses Estimates as Company Advances Cell Therapy Pipeline INAB Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Advances Pipeline